Yasuhiko Komatsu

Title: Yasuhiko Komatsu: Innovator in Monoclonal Antibody Development

Introduction

Yasuhiko Komatsu is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 3 patents to his name, his work has had a considerable impact on medical research and pharmaceutical applications.

Latest Patents

One of Yasuhiko Komatsu's latest patents is focused on an acetyllysine-recognizing monoclonal antibody and the process for producing it. This innovative antibody is capable of recognizing N-acetyllysine regardless of the types of adjacent amino acids. The monoclonal antibody features a light chain with a specific amino acid sequence and a heavy chain that also has a defined sequence, allowing it to accept adjacent amino acids over a broad range. Another significant patent involves cyclic tetrapeptide derivatives and their pharmaceutical uses, showcasing his versatility in research.

Career Highlights

Throughout his career, Yasuhiko Komatsu has worked with prominent companies such as Japan Energy Corporation and Sumitomo Pharmaceuticals Company Limited. His experience in these organizations has contributed to his expertise in the field of biotechnology and pharmaceuticals.

Collaborations

Yasuhiko has collaborated with notable colleagues, including Minoru Yoshida and Norikazu Nishino. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in his field.

Conclusion

Yasuhiko Komatsu's contributions to monoclonal antibody development and his innovative patents reflect his dedication to advancing biotechnology. His work continues to influence the medical and pharmaceutical industries, making him a significant figure in the realm of scientific innovation.